Doximity’s AI-Powered Tools Set New Adoption Record—Is the Healthcare Platform Entering Its Next Growth Phase?
AI Integration Across Healthcare Workflows Drives Revenue and User Growth
Doximity, Inc. (NYSE:DOCS) reported an impressive 23% year-over-year increase in revenue for its fiscal 2026 second quarter, hitting $168.5 million. This surge comes as the company’s AI-powered clinical workflow tools achieve record usage: over 80% of U.S. physicians now leverage the platform, and AI Scribe and DoxGPT user numbers jumped more than 50% from the prior quarter. Altogether, 650,000 prescribers now utilize Doximity’s workflow suite to streamline clinical documentation and patient care—a clear signal that healthcare AI is moving beyond limited pilots and into large-scale adoption.
Strong Cash Flow and Upgraded Guidance Highlight Momentum
Alongside its revenue growth, Doximity delivered operating cash flow of $93.9 million, marking a 37% rise year-over-year. Management responded to the platform’s surging adoption by raising full fiscal year 2026 revenue guidance to between $640 million and $646 million. The digital platform’s AI-powered tools are rapidly becoming standard practice, supporting doctors with both virtual patient visits and back-office documentation.
| Key Metrics (Q2 Fiscal 2026) | Value |
|---|---|
| Revenue (YoY Growth) | $168.5M (23%) |
| Operating Cash Flow (YoY Growth) | $93.9M (37%) |
| AI Workflow Tools Adoption (QoQ Growth) | +50% |
| Prescribers Using Workflow Tools | 650,000 |
| Physician Platform Reach (U.S.) | >80% |
| Updated Full-Year Revenue Guidance | $640M – $646M |
AI-Powered Tools are Becoming an Industry Standard
Doximity’s platform now integrates new clinical reference and search features, helping doctors quickly access peer-reviewed medical literature and manage both virtual patient care and administrative processes. The result is time savings for physicians and faster, more efficient patient care. According to CEO Jeff Tangney, "Our platform continues to grow with new AI tools to save physicians' time," which is reflected in the sharp rise in workflow tool adoption and overall platform engagement.
Healthcare AI Moves From Pilot Phase to Broad Production
Industry-wide, the healthcare sector is witnessing a structural shift. With 80% of hospitals now using AI to enhance operational efficiency and patient care, AI platforms like Doximity’s are well-positioned to become essential digital infrastructure. Early movers in the healthcare AI space have the opportunity to establish durable market advantages as hospitals prioritize automation and workflow streamlining over mere experimentation.
What This Means for Investors and the Healthcare Sector
Doximity’s record user growth and upwardly revised guidance underscore both robust financial health and significant demand for AI solutions among healthcare professionals. As more hospitals move to enterprise-scale AI deployments, companies with established physician networks and AI-powered offerings—such as Doximity—may find themselves leading the next wave of industry transformation. Investors, analysts, and healthcare insiders may want to keep a close eye on whether Doximity can maintain this pace as AI becomes foundational in healthcare’s digital evolution.
Contact Information:
If you have feedback or concerns about the content, please feel free to reach out to us via email at support@marketchameleon.com.
About the Publisher - Marketchameleon.com:
Marketchameleon is a comprehensive financial research and analysis website specializing in stock and options markets. We leverage extensive data, models, and analytics to provide valuable insights into these markets. Our primary goal is to assist traders in identifying potential market developments and assessing potential risks and rewards.
NOTE: Stock and option trading involves risk that may not be suitable for all investors. Examples contained within this report are simulated and may have limitations. Average returns and occurrences are calculated from snapshots of market mid-point prices and were not actually executed, so they do not reflect actual trades, fees, or execution costs. This report is for informational purposes only, and is not intended to be a recommendation to buy or sell any security. Neither Market Chameleon nor any other party makes warranties regarding results from its usage. Past performance does not guarantee future results. Please consult a financial advisor before executing any trades. You can read more about option risks and characteristics at theocc.com.
The information is provided for informational purposes only and should not be construed as investment advice. All stock price information is provided and transmitted as received from independent third-party data sources. The Information should only be used as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments and trading strategies. The Company does not guarantee the accuracy, completeness or timeliness of the Information.
Disclosure: This article was generated with the assistance of AI